Medtronic Releases Results of SYMPLICITY HTN-3

[Thomson Reuters ONE] – Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA MINNEAPOLIS and WASHINGTON, DC – March 29, 2014 – Medtronic, Inc. (NYSE: MDT) today announced … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view